Mechanisms of Risk Reduction in the Clinical Practice of Alzheimer’s Disease Prevention

Alzheimer’s disease (AD) is a neurodegenerative dementia that affects nearly 50 million people worldwide and is a major source of morbidity, mortality, and healthcare expenditure. While there have been many attempts to develop disease-modifying therapies for late-onset AD, none have so far shown eff...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Aging Neurosci
Main Authors: Schelke, Matthew W., Attia, Peter, Palenchar, Daniel J., Kaplan, Bob, Mureb, Monica, Ganzer, Christine A., Scheyer, Olivia, Rahman, Aneela, Kachko, Robert, Krikorian, Robert, Mosconi, Lisa, Isaacson, Richard S.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Neuroscience
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5907312/
https://ncbi.nlm.nih.gov/pubmed/29706884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2018.00096
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados